Skip to menu Skip to content Skip to footer

2021

Conference Publication

Risks of under-treating and over-treating disease

An, Yoon-Kyo (2021). Risks of under-treating and over-treating disease. IBD 2020: Right Therapy, Right Patient, Right Time#Choosing Wisely, Proceedings of the Takeda IBD Symposium, Virtual, 5 September 2020. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.15458

Risks of under-treating and over-treating disease

2020

Journal Article

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study

Haifer, Craig, Srinivasan, Ashish, An, Yoon‐Kyo, Picardo, Sherman, Langenberg, Daniel, Menon, Shankar, Begun, Jakob, Ghaly, Simon and Thin, Lena (2020). Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study. Medical Journal of Australia, 214 (3) mja2.50824, 128-133. doi: 10.5694/mja2.50824

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study

2020

Journal Article

Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography

Flanagan, Emma, Wright, Emily K., Begun, Jakob, Bryant, Robert V., An, Yoon-Kyo, Ross, Alyson L., Kiburg, Katerina V. and Bell, Sally J. (2020). Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography. Journal of Crohn's and Colitis, 14 (10), 1405-1412. doi: 10.1093/ecco-jcc/jjaa082

Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography

2019

Journal Article

Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysis

An, Yoon‐Kyo, Prince, David, Gardiner, Fergus, Neeman, Teresa, Linedale, Ecushla C., Andrews, Jane M., Connor, Susan and Begun, Jakob (2019). Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysis. Medical Journal of Australia, 211 (10) mja2.50384, 461-467. doi: 10.5694/mja2.50384

Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysis

2019

Journal Article

Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledge

Rajagopalan, Arvind, Sathananthan, Dharshan, An, Yoon‐Kyo, Van De Ven, Lucinda, Martin, Serena, Fon, James, Costello, Samuel P, Begun, Jakob and Bryant, Robert V (2019). Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledge. JGH Open, 4 (2) jgh3.12268, 267-272. doi: 10.1002/jgh3.12268

Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledge

2019

Journal Article

Systematic review and meta-analysis: optimal salvage therapy in acute severe ulcerative colitis

Choy, Matthew C., Seah, Dean, Faleck, David M., Shah, Shailja C., Chao, Che-Yung, An, Yoon-Kyo, Radford-Smith, Graham, Bessissow, Talat, Dubinsky, Marla C., Ford, Alexander C., Churilov, Leonid, Yeomans, Neville D. and De Cruz, Peter P. (2019). Systematic review and meta-analysis: optimal salvage therapy in acute severe ulcerative colitis. Inflammatory Bowel Diseases, 25 (7), 1169-1186. doi: 10.1093/ibd/izy383

Systematic review and meta-analysis: optimal salvage therapy in acute severe ulcerative colitis

2019

Conference Publication

Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study

Haifer, C., Srinivasan, A., Menon, S., An, Y., Picardo, S., Van Langenberg, D., Begun, J., Ghaly, S. and Thin, L. (2019). Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA, Australia, 8–10 September 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.14801

Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study

2019

Conference Publication

Effectiveness of fecal calprotectin testing to identify patients with organic gastrointestinal diseases: a systematic review and diagnostic meta-analysis

An, Y., Prince, D., Gardiner, F., Linedale, E., Andrews, J., Connor, S. and Begun, J. (2019). Effectiveness of fecal calprotectin testing to identify patients with organic gastrointestinal diseases: a systematic review and diagnostic meta-analysis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, South Australia, 8-10 September 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.14803

Effectiveness of fecal calprotectin testing to identify patients with organic gastrointestinal diseases: a systematic review and diagnostic meta-analysis

2018

Journal Article

Predicting response after infliximab salvage in acute severe ulcerative colitis

Choy, Matthew C., Seah, Dean, Gorelik, Alexandra, An, Yoon-Kyo, Chen, Cheng-Yu, Macrae, Finlay A., Sparrow, Miles P., Connell, William R., Moore, Gregory T., Radford-Smith, Graham, Van Langenberg, Daniel R. and De Cruz, Peter (2018). Predicting response after infliximab salvage in acute severe ulcerative colitis. Journal of Gastroenterology and Hepatology, 33 (7), 1347-1352. doi: 10.1111/jgh.14072

Predicting response after infliximab salvage in acute severe ulcerative colitis

2016

Conference Publication

Demyelination during infliximab therapy for crown's disease

An, Y. K., Allsop, S., Daveson, K.L. and Daveson, A. J. M. (2016). Demyelination during infliximab therapy for crown's disease. Australian Gastroenterology Week, Adelaide, SA, Australia, 10–12 October 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13522

Demyelination during infliximab therapy for crown's disease

2016

Conference Publication

The incidence of 30-day adverse events after colonoscopy in an IBD population

An, Y. K., Wong, J., You, I. S., Mortimore, M., Hewett, D. G., Appleyard, M. N. and Begun, J. (2016). The incidence of 30-day adverse events after colonoscopy in an IBD population. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, South Australia, Australia, 10–12 October 2016. HOBOKEN: WILEY-BLACKWELL. doi: 10.1111/jgh.13522

The incidence of 30-day adverse events after colonoscopy in an IBD population

2012

Conference Publication

The impact of carbon dioxide insufflation on abdominal pain after colonoscopy

An, Y. K., Hewett, D. G. and Appleyard, M. N. (2012). The impact of carbon dioxide insufflation on abdominal pain after colonoscopy. Digestive Disease Week (DDW), San Diego Ca, May 19-22, 2012. NEW YORK: MOSBY-ELSEVIER.

The impact of carbon dioxide insufflation on abdominal pain after colonoscopy

2012

Conference Publication

A systematic analysis of complication rates of colonoscopy in an Australian teaching hospital

Finch, A., An, Y., Hewett, D. and Appleyard, M. (2012). A systematic analysis of complication rates of colonoscopy in an Australian teaching hospital. RACP Future Directions in Health Congress 2012, Brisbane, QLD, Australia, 6-9 May 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1445-5994.2012.02780.x

A systematic analysis of complication rates of colonoscopy in an Australian teaching hospital

2012

Conference Publication

A systematic analysis of complication rates of colonoscopy in a teaching hospital

An, Y. K., Hewett, D. G., Vandeleur, A. E. and Appleyard, M. N. (2012). A systematic analysis of complication rates of colonoscopy in a teaching hospital. Digestive Disease Week (DDW), San Diego, CA, USA, May 19-22, 2012. NEW YORK: MOSBY-ELSEVIER.

A systematic analysis of complication rates of colonoscopy in a teaching hospital

2012

Conference Publication

The impact of carbon dioxide insufflation on abdominal pain after colonoscopy

Finch, A., An, Y., Hewett, D. and Appleyard, M. (2012). The impact of carbon dioxide insufflation on abdominal pain after colonoscopy. RACP Future Directions in Health Congress 2012, Brisbane QLD, Australia, 6-9 May 2012. Richmond Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1445-5994.2012.02780.x

The impact of carbon dioxide insufflation on abdominal pain after colonoscopy

2011

Conference Publication

A systematic analysis of complication rates of colonoscopy in an Australian teaching hospital

An, Y. K., Hewett, D. G., Sexton, J., Vandeleur, A. and Appleyard, M. N. (2011). A systematic analysis of complication rates of colonoscopy in an Australian teaching hospital. Australian Gastroenterology Week 2011, Brisbane, Qld., Australia, 12-15 September 2011. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2011.06821.x

A systematic analysis of complication rates of colonoscopy in an Australian teaching hospital

2011

Conference Publication

The impact of carbon dioxide insufflation on abdominal pain after colonoscopy

An, Y. K., Hewett, D. G. and Appleyard, M. N. (2011). The impact of carbon dioxide insufflation on abdominal pain after colonoscopy. Australian Gastroenterology Week 2011, Brisbane, Australia, 12-15 September 2011. MALDEN: MOSBY-ELSEVIER.

The impact of carbon dioxide insufflation on abdominal pain after colonoscopy